Stocktoria
GLOBUS MEDICAL INC GMED
NYSE · XNYS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2012-03-08
GLOBUS MEDICAL INC financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.9B | $2.5B | $1.6B | $1.0B | $958.1M |
| Gross profit | — | — | $1.0B | $759.1M | $718.9M |
| R&D expense | $147.2M | $163.8M | $124.0M | $73.0M | $97.3M |
| SG&A expense | $1.2B | $981.4M | $643.8M | $432.1M | $408.1M |
| Operating income | $479.8M | $166.0M | $133.1M | $228.0M | $172.0M |
| Income tax | $67.2M | $17.7M | $42.5M | $52.9M | $31.2M |
| Net income | $537.9M | $103.0M | $122.9M | $190.2M | $149.2M |
| EPS (diluted) | $3.92 | $0.75 | $1.07 | $1.85 | $1.44 |
| Operating cash flow | $753.4M | $520.6M | $243.5M | $178.5M | $276.3M |
| Free cash flow | $588.8M | $405.2M | $165.2M | $104.4M | $219.4M |
| Cash & equivalents | $526.2M | $784.4M | — | — | — |
| Inventory | $759.3M | $659.2M | $848.1M | $299.0M | $237.0M |
| Total assets | $5.3B | $5.3B | $5.1B | $2.1B | $2.0B |
| Total liabilities | $729.5M | $1.1B | $1.1B | $229.8M | $215.9M |
| Shareholders' equity | $4.6B | $4.2B | $4.0B | $1.8B | $1.7B |
Source: SEC EDGAR filings · CIK 0001237831 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.